Alcon to Acquire PowerVision for $285M

 Alcon to Acquire PowerVision for $285M

Alcon to Acquire PowerVision for $285M

Shots:

  • Alcon acquires PowerVision, in all stock transaction paying $285M to PowerVision with additional payment based on regulatory & commercial milestones expected to initiate in 2023
  • The focus of the acquisition is to expand Alcon’s ophthalmic portfolio by using PowerVision’sadvanced technology intraocular lenses (AT-IOLS) to deliver therapies cataract surgery patients desiring spectacle independence
  • PowerVision’s AT-IOLS is used to develop fluid-based accommodating intraocular lenses that utilize eye’s natural accommodating response in presbyopia providing near & intermediate vision

Click here to read full press release/ article | Ref: Alcon | Image: Cnbc

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post